CVE-2020-27256

Name: CVE-2020-27256
Creator: NVD / NIST
Published: 2021-01-19T21:15:13.967+00:00
License: https://creativecommons.org/publicdomain/zero/1.0/

MEDIUMCVSS 6.8/10EPSS 0.31%

Last modified Jun 17, 2026

CVE-2020-27256 is a medium-severity vulnerability rated 6.8/10 on the CVSS scale. In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, a hard-coded physician PIN in the physician menu of the insulin pump allows attackers with physical access to change insulin therapy settings.. EPSS estimates a 0.31% chance of exploitation in the next 30 days.

Description

In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, a hard-coded physician PIN in the physician menu of the insulin pump allows attackers with physical access to change insulin therapy settings.

Metrics

CVSS 3.1

6.8/10

CVSS:3.1/AV:P/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

EPSS Probability

0.31%

22.8th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

Affected Software

Vendor	Product	Versions
Sooil	Anydana-A Firmware	< 3.0
Sooil	Anydana-I Firmware	< 3.0
Sooil	Diabecare Rs Firmware	< 3.0

References

https://us-cert.cisa.gov/ics/advisories/icsma-21-012-01Third Party Advisory, US Government Resource
https://us-cert.cisa.gov/ics/advisories/icsma-21-012-01Third Party Advisory, US Government Resource

Timeline

Published: Jan 19, 2021
Last Modified: Jun 17, 2026
Status: Modified

Frequently Asked Questions

What is CVE-2020-27256?

How severe is CVE-2020-27256?

CVE-2020-27256 has a CVSS score of 6.8/10 (MEDIUM severity). The EPSS model estimates a 0.31% probability of exploitation in the next 30 days.

How do I fix CVE-2020-27256?

Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2020-27256?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST